Efflux Limits Tumor Drug Delivery Despite Disrupted BBB
- PMID: 33736874
- DOI: 10.1016/j.tips.2021.03.001
Efflux Limits Tumor Drug Delivery Despite Disrupted BBB
Abstract
Apparent blood-brain barrier (BBB) disruption is common in glioblastoma (GBM), but has not translated to improved drug delivery efficacy. Recently, de Gooijer et al. demonstrated that efflux transporters can have a prominent role in limiting drug delivery. These transport systems contribute to ineffective drug delivery to tumor cells in the brain.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Comment on
-
Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.Clin Cancer Res. 2010 Dec 1;16(23):5664-78. doi: 10.1158/1078-0432.CCR-10-1564. Epub 2010 Sep 9. Clin Cancer Res. 2010. PMID: 20829328 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical